Skip to main content
European patent to be granted to MilliporeSigma's CRISPR technology
8/11/2017

MilliporeSigma, Merck's life science division, received a Notice of Intention to Grant from the European Patent Office for its CRISPR technology, which allows researchers to replace mutations with a functional sequence. The approval will make this only the second patent to be awarded in Europe for gene-editing technology.

Full Story: